Related Experiment Videos
"Side balloon stenting": a novel technique for bifurcation lesions
L Spedicato1, M Bonin, G Bernardi
1Cardiac Catheterization Laboratory, Department of Cardiovascular Sciences, Az. Osp. S. M. della Misericordia, Udine, Italy. emodinamica.aoud.sanita.fvg.it
The Journal of Invasive Cardiology
|October 3, 2001
Summary
A new "side balloon stenting" technique safely treats coronary bifurcations, often using a single stent. This method avoids guidewire removal, preventing complications and plaque shifting during stenting procedures.
Area of Science:
- Interventional Cardiology
- Cardiovascular Interventions
- Medical Device Technology
Background:
- Coronary artery bifurcations represent complex lesions requiring specialized treatment strategies.
- Existing techniques for bifurcation stenting can be associated with complications such as guidewire entrapment and plaque shift.
Purpose of the Study:
- To introduce and evaluate a novel technique, "side balloon stenting," for treating coronary bifurcation stenoses.
- To assess the feasibility, safety, and procedural success of the "side balloon stenting" technique.
Main Methods:
- The "side balloon stenting" technique involves performing kissing balloon angioplasty and stent implantation while leaving guidewires in place.
- The technique was applied in 29 patients with coronary artery bifurcations.
- Technical and angiographic success rates were assessed, along with procedural outcomes.
Main Results:
- The technical success rate for "side balloon stenting" was 90% (25/29 procedures).
- Angiographic success (residual stenosis < 30% and TIMI 3 flow) was achieved in 100% of cases.
- In 82% of successful procedures, only a single stent was implanted in the main vessel, avoiding side branch stenting.
Conclusions:
- The "side balloon stenting" technique is a feasible and safe approach for treating coronary bifurcations.
- The technique demonstrates a high procedural success rate and effectively minimizes the need for side branch stenting.
- Long-term outcomes, particularly restenosis rates, require further evaluation to confirm sustained benefits.